Effect of Pulsed Electromagnetic Field on MMP-9 and TIMP-1 Levels in Chondrosarcoma Cells Stimulated with IL-1β

  • Caliskan, Serife Gokce (Department of Biophysics, Institute of Health Sciences, Medical Faculty, Adnan Menderes University) ;
  • Bilgin, Mehmet Dincer (Department of Biophysics, Medical Faculty, Adnan Menderes University) ;
  • Kozaci, Leyla Didem (Department of Medical Biochemistry, Medical Faculty, Adnan Menderes University)
  • Published : 2015.04.14


Chondrosarcoma, the second most common type of bone malignancy, is characterized by distant metastasis and local invasion. Previous studies have shown that treatment by pulsed electromagnetic field (PEMF) has beneficial effects on various cancer cells. In this study, we investigated the effects of PEMF applied for 3 and 7 days on the matrix metalloproteinase (MMP) levels in chondrosarcoma SW1353 cells stimulated with two different doses of $IL-1{\beta}$. SW1353 cells were treated with (0.5 and 5 ng/ml) $IL-1{\beta}$ and PEMF exposure was applied either 3 or 7 days. MMP-9 and TIMP-1 levels were measured in conditioned media by enzyme-linked immunosorbent assay. The results were relative to protein levels. Statistical analyses were performed using one-way analysis of variance (ANOVA). P<0.05 was considered significant. PEMF treatment significantly decreased MMP-9 protein levels in human chondrosarcoma cells stimulated with 0.5 ng/ml $IL-1{\beta}$ at day 7, whereas it did not show any effect on cells stimulated with 5 ng/ml $IL-1{\beta}$. There was no significant change in TIMP-1 protein levels either by $IL-1{\beta}$ stimulation or by PEMF treatment. The results of this study showed that PEMF treatment suppressed $IL-1{\beta}$-mediated upregulation of MMP-9 protein levels in a dual effect manner. This finding may offer new perspectives in the therapy of bone cancer.


Pulsed electromagnetic field;bone cancer;chondrocytes;matrix metalloproteinase


  1. Akhtar N, Miller MJS, Haqqi TM (2011). Effect of a Herbal-Leucine mix on the IL-$1{\beta}$-induced cartilage degradation and infflammatory gene expression in human chondrocytes. BMC Complement Altern Med, 11, 66.
  2. Baker JF, Walsh PM, Byrne DP, et al (2012). Pravastatin suppresses matrix metalloproteinase expression and activity in human articular chondrocytes stimulated by interleukin-$1{\beta}$. J Orthop Traumatol, 13, 119-23.
  3. Benassi MS, Gamberi G, Magagnoli G, et al (2001). Metalloproteinase expression and prognosis in soft tissue sarcomas. Ann Oncol, 12, 75-80.
  4. Bevill SL, Briant PL, Levenston ME, et al (2009). Central and peripheral region tibial plateau chondrocytes respond differently to in vitro dynamic compression. Osteoarthr Cartil, 17, 980-7.
  5. Bobacz K, Graninger WB, Amoyo L, et al (2006). Effect of pulsed electromagnetic fields on proteoglycan biosynthesis of articular cartilage is age dependent. Ann Rheum Dis, 65, 949-51.
  6. Chang CH, Loo ST, Liu HL, et al (2010). Can low frequency electromagnetic field help cartilage tissue engineering? J Biomed Mater Res A, 92, 843-851.
  7. Ciombor DM, Lester G, Aaron RK, et al (2002). Low frequency EMF regulates chondrocyte differentiation and expression of matrix proteins. J Orthop Res, 20, 40-50.
  8. Crocetti S, Beyer C, Schade G, et al (2013). Low intensity and frequency pulsed electromagnetic fields selectively impair breast cancer cell viability. PLOS One, 8. 72944.
  9. Daniel C, Duffield J, Brunner T, et al (2001). Matrix metalloproteinase inhibitors cause cell cycle arrest and apoptosis in glomerular messangial cells. J Pharmacol Exp Ther, 297, 57-68.
  10. De Mattei M, Caruso A, Pezzetti F, et al (2001). Effects of pulsed electromagnetic fields on human articular chondrocyte proliferation. Connect Tissue Res, 42, 269-279.
  11. De Mattei M, Pasello M, Pellati A, et al (2003). Effects of electromagnetic fields on proteoglycan metabolism of bovine articular cartilage explants. Connect Tissue Res, 44, 154-9.
  12. Dunn SL, Wilkinson JM, Crawford A, et al (2013). Cannabinoid WIN-55,212-2 mesylate inhibits interleukin-$1{\beta}$ induced matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase expression in human chondrocytes. Osteoarthr Cartil.
  13. Fioravanti A, Nerucci F, Collodel G, et al (2002). Biochemical and morphological study of human articular chondrocytes cultivated in the presence of pulsed signal therapy. Ann Rheum Dis, 61, 1032-3.
  14. Gebauer M, Saas J, Sohler F, et al (2005). Comparison of the chondrosarcoma cell line SW1353 with primary human adult articular chondrocytes with regard to their gene expression profile and reactivity to IL-1beta. Osteoarthr Cartil, 13, 697-708.
  15. Kaszuba-Zwoinska J, Wojcik K, Bereta M, et al (2010). Pulsating electromagnetic field stimulation prevents cell death of Puromycin treated U937 cell line. J Physiol Pharmacol, 61, 201-5.
  16. Klatt AR, Klinger G, Neumuller O, et al (2006). TAK1 downregulation reduces $IL1{\beta}$ induced expression of MMP13, MMP1 and TNF-alpha. Biomedicine & Pharmacotherapy, 60, 55-61.
  17. Lee S G, Lee EJ, Park WD, et al (2012). Anti-inflammatory and anti-osteoarthritis effects of fermented Achyrantes japonica Nakai. J Ethnopharmacol, 142, 634-41.
  18. Lim H, Park H, Kim HP (2011). Effects of flavonoids on matrix metalloproteinase-13 expression of interleukin-$1{\beta}$-treated articular chondrocytes and their cellular mechanisms: Inhibition of c-Fos/AP-1 and JAK/STAT signaling pathways. J Pharmacol Sci, 116, 221-31.
  19. Lu YC, Jayakumar T, Duann YF, et al (2011). Chondroprotective role of sesamol by inhibiting MMP expression via retaining NF-${\kappa}B$ signaling in activated SW1353 cells. J Agric Food Chem, 59, 4969-78.
  20. Nelson AR, Fingleton B, Rothenberg ML, et al (2000). Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol, 18, 1135-49.
  21. Ongaro A, Pellati A, Masieri FF, et al (2011). Chondroprotective effects of pulsed electromagnetic fields on human cartilage explants. Bioelectromagnetics, 32, 543-51.
  22. Patruno A, Pesce M, Marrone A, et al (2012). Activity of matrix metalloproteinases (MMP) and the tissue inhibitor of MMP (TIMP)-1 in electromagnetic field-exposed THP-1 cells. J Cell Physiol, 227, 2767-74.
  23. Pei Y, Harvey A, Yu XP, et al (2006). Differential regulation of cytokine-induced MMP-1 and MMP-13 expression by p38 kinase inhibitors in human chondrosarcoma cells: potential role of Runx2 in mediating p38 effects. Osteoarthr Cartil, 14, 749-58.
  24. Qiu LB, Zhou Y, Wang Q, et al (2011). Synthetic gelatinases inhibitor attenuates electromagnetic pulse-induced blood-brain barrier disruption by inhibiting gelatinases-mediated ZO-1 degradation in rats. Toxicology, 285, 31-8.
  25. Roebuck MM, Helliwell TR, Chaudhry IH, et al (2005). Matrix metalloproteinase expression is related to angiogenesis and histologic grade in spindle cell soft tissue neoplasms of the extremities. Am J Clin Path, 123, 405-14.
  26. Roomi MW, Kalinovsky T, Niedzwiecki A, et al (2013a). Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in adult human sarcoma cell lines. Int J Oncol, 43, 39-49.
  27. Roomi MW, Kalinovsky T, Monterrey J, et al (2013b). In vitro modulation of MMP-2 and MMP-9 in adult human sarcoma cell lines by cytokines, inducers and inhibitors. Int J Oncol, 43, 1787-98.
  28. Sadoghi P, Leithner A, Dorotka R, et al (2013). Effect of pulsed electromagnetic fields on the bioactivity of human osteoarthritic chondrocytes. Orthopedics, 36, 360-5.
  29. Shang HS, Chang JB, Lin JH, et al (2014). Deguelin inhibits the migration and invasion of U-2 OS human osteosarcoma cells via the inhibition of matrix metalloproteinase-2/-9 in vitro. Molecules, 19, 16588-608.
  30. Shi J, Schmitt-Talbot E, Di Mattia DA, et al (2004). The differential effects of IL-1 and TNF-alpha on proinflammatory cytokine and matrix metalloproteinase expression in human chondrosarcoma cells. Inflamm Res, 53, 377-89.
  31. Tang CH, Tsai CC (2012). CCL2 increases MMP-9 expression and cell motility in human chondrosarcoma cells via the Ros/Raf/MEK/ERK/NF-KB signaling pathway. Biochem Pharmacol, 83, 335-44.
  32. Trindade MC, Shida J, Ikenoue T, et al (2004). Intermittent hydrostatic pressure inhibits matrix metalloproteinase and pro-inflammatory mediator release from human osteoarthritic chondrocytes in vitro. Osteoarthr Cartil, 12, 729-35.
  33. Vincenti MP, Brinckerhoff CE (2001). Early response genes induced in chondrocytes stimulated with the inflammatory cytokine interleukin-1beta. Arthritis Res, 3, 381-8.
  34. Vincenzi F, Targa M, Corciulo C, et al (2012). The anti-tumor effect of A3 adenosine receptors is potentiated by pulsed electromagnetic fields in cultured neural cancer cells. PLOS One, 39317.
  35. Wang C, Ma HX, Jin MS, et al (2014). Association of matrix metalloproteinase (MMP)-2 and -9 expression with extra-gastrointestinal stromal tumor metastasis. Asian Pac J Cancer Prev, 15, 4187-92.
  36. Wei C, Bai WK, Wang Y, et al (2014). Combined treatment of PC-3 cells with ultrasound and microbubbles suppresses invasion and migration. Oncol Lett, 8, 1372-6.
  37. Yadav L, Puri N, Rastogi N, et al (2014). Matrix metalloproteinases and cancer-roles in threat and therapy. Asian Pac J Cancer Prev, 15, 1085-91.
  38. Zhang D, Pan X, Ohno S, et al (2011). No effects of pulsed electromagnetic fields on expression of cell adhesion molecules (integrin CD44) and matrix metalloproteinase-2/9 in osteosarcoma cell lines. Bioelectromagnetics, 32, 463-473.
  39. Zhao F, Li L, Gua L, et al (2014). Roles for GP IIb/IIIa and ${\alpha}v{\beta}3$ integrins in MDA-MB-231 cell invasion and shear flow-induced cancer cell mechanotransduction. Cancer Letters, 334, 62-73.
  40. Zhu Z, Wang CP, Zhang YF, et al (2014). MicroRNA-100 resensitizes resistant chondrosarcoma cells to cisplatin through direct targeting of mTOR. Asian Pac J Cancer Prev, 15, 917-923.
  41. Zitka O, Kukacka J, Krizkova S, et al (2010). Matrix metalloproteinases. Cur Med Chem, 17, 3751-68.

Cited by

  1. Effects of radiation from a radiofrequency identification (RFID) microchip on human cancer cells vol.92, pp.3, 2016,
  2. Radioprotective effect of Date syrup on radiation- induced damage in Rats vol.8, pp.1, 2018,